You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for Patent: 6,977,298


✉ Email this page to a colleague

« Back to Dashboard


Title: Tricyclic inhibitors of poly(ADP-ribose) polymerases
Abstract:Compounds of the formula below are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease. ##STR1## As cancer therapeutics, the compounds of the invention may be used, e.g., in combination with cytotoxic agents and/or radiation.
Inventor(s): Webber; Stephen Evan (San Diego, CA), Canan-Koch; Stacie S. (La Jolla, CA), Tikhe; Jayashree (San Diego, CA), Thoresen; Lars Henrik (College Station, TX)
Assignee: Agouron Pharmacetucals, Inc. (La Jolla, CA) Cancer Research Campaign Technology Limited (London, GB)
Filing Date:Dec 03, 2004
Application Number:11/004,261
Claims:1. A method of preparing a compound of formula I ##STR140##

wherein R.sup.1 is hydrogen or halogen; R.sup.2 is hydrogen or methyl; R.sup.3 is: optionally substituted aryl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, heteroaryl; or --C(O)OR.sup.7, wherein R.sup.7 is optionally substituted alkyl; n is 1 or 2;

the method comprising: a) converting a compound of formula II, wherein R.sup.4 is --(CH.sub.2).sub.n NH.sub.2 ; R.sup.5 is --CO.sub.2 CH.sub.3 ##STR141##

into a compound of formula III ##STR142## b) converting the compound of formula III into a compound of formula IV, wherein X is bromine or iodine; and ##STR143## c) transforming the compound of formula IV into the compound of formula I.

2. The method of claim 1, wherein the compound of formula II is formed by reduction of a compound of formula V, wherein R.sup.6 is --CH.dbd.NOH or --CH.dbd.CHNO.sub.2. ##STR144##

3. The method of claim 2, wherein the compound of formula V is formed by transformation of the compound of formula VI. ##STR145##

4. The method of claim 3, wherein the compound of formula VI is formed by Vilsmeier formylation or Friedel-Crafts acylation of the compound of formula VII. ##STR146##

5. The method of claim 1, wherein the step b) comprises treating the compound of formula III with pyridinium tribromide to form the compound of formula IV.

6. The method of claim 1, wherein the step c) comprises reacting the compound of formula IV with R.sup.3 B(OH).sub.2 in the presence of tetrakis(triphenylphosphine)palladium to form the compound of formula I, wherein R.sup.3 is optionally substituted aryl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, heteroaryl.

7. The method of claim 1 further comprising reacting the compound of formula I, wherein R.sup.1 is fluorine, R.sup.2 is hydrogen, R.sup.3 is -Ph-CHO, n is 2, with methylamine to form the compound of formula I, wherein R.sup.1 is fluorine, R.sup.2 is hydrogen, R.sup.3 is -Ph-CH.sub.2 --NCH.sub.3.

8. The method of claim 1, wherein the step c) comprises reacting the compound of formula IV with Pd/CO/R.sup.7 OH, wherein R.sup.7 is optionally substituted alkyl, to form the compound of formula I, wherein R.sup.3 is --C(O)OR.sup.7.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.